» Articles » PMID: 32689703

COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network

Abstract

The extraordinary demands of managing the COVID-19 pandemic has disrupted the world's ability to care for patients with thoracic malignancies. As a hospital's COVID-19 population increases and hospital resources are depleted, the ability to provide surgical care is progressively restricted, forcing surgeons to prioritize among their cancer populations. Representatives from multiple cancer, surgical, and research organizations have come together to provide a guide for triaging patients with thoracic malignancies as the impact of COVID-19 evolves as each hospital.

Citing Articles

The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy.

Mangone L, Marinelli F, Bisceglia I, Filice A, De Leonibus L, Rapicetta C Biology (Basel). 2023; 12(3).

PMID: 36979081 PMC: 10045495. DOI: 10.3390/biology12030390.


Lessons learned by thoracic surgeons during the COVID-19 pandemic.

Madsen H, Lambert-Kerzner A, Mucharsky E, Phillips J, David E, Odell D J Thorac Dis. 2023; 15(2):507-515.

PMID: 36910104 PMC: 9992568. DOI: 10.21037/jtd-22-920.


Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic.

Mayne N, Bajaj S, Powell J, Elser H, Civiello B, Fintelmann F Clin Lung Cancer. 2022; 23(6):e362-e376.

PMID: 35660355 PMC: 9068243. DOI: 10.1016/j.cllc.2022.05.001.


Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.

Chiner-Vives E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, Izquierdo-Alonso J, Otero-Candelera R Arch Bronconeumol. 2022; 58 Suppl 1:39-50.

PMID: 35501222 PMC: 9012323. DOI: 10.1016/j.arbres.2022.03.011.


From Pandemic to Endemic-Redefining Excellence in Thoracic Surgery Service Delivery.

Leow L, Tam J Front Surg. 2021; 8:741366.

PMID: 34957198 PMC: 8702421. DOI: 10.3389/fsurg.2021.741366.


References
1.
Cabrini L, Landoni G, Zangrillo A . Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet. 2020; 395(10225):685. PMC: 7137083. DOI: 10.1016/S0140-6736(20)30359-7. View

2.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

3.
Levinsky N, Wima K, Morris M, Ahmad S, Shah S, Starnes S . Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019; 159(6):2555-2566. DOI: 10.1016/j.jtcvs.2019.09.169. View

4.
Samson P, Crabtree T, Robinson C, Morgensztern D, Broderick S, Krupnick A . Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017; 103(4):1070-1075. PMC: 5444908. DOI: 10.1016/j.athoracsur.2016.09.053. View

5.
Rosen J, Salazar M, Wang Z, Yu J, Decker R, Kim A . Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016; 152(1):44-54.e9. DOI: 10.1016/j.jtcvs.2016.03.060. View